Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000785 · ClinicalTrials.gov registry record
A Registry of Tuberculosis Cases in the CPCRA
A clinical trial of HIV Infections and Tuberculosis, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Completed
- Registry status
- 1,509
- Enrollment target
- 13
- Study locations
NCT00000785 is a study of HIV Infections and Tuberculosis that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 1,509 participants, above the 443-participant average among 542 other HIV Infections trials with a reported enrollment target (241% higher). The trial reports 13 study locations across 9 states.
The verdict
NCT00000785, a study of HIV Infections and Tuberculosis, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- COMPLETED
- Registry status
- 1,509 participants
- Enrollment target
- 13
- Study locations
Study Summary
PRIMARY: To estimate the proportion of tuberculosis patients in the CPCRA who have drug-resistant tuberculosis (TB) and to describe the patterns of drug resistance. SECONDARY: To compare drug resistance data on the Mycobacterium tuberculosis isolates of HIV-infected patients to those of HIV-uninfected patients who are being followed in the CPCRA. To assess the relationship of resistance data with geographic, demographic, and HIV and TB risk factor information. Geographic areas and demographic subgroups affected by the TB epidemic appear to be congruent and associated with the concurrent HIV epidemic. The total number of CPCRA patients who will develop, or who have experienced, confirmed TB is unknown. It is critical to determine the depth and breadth of the current problem of drug-resistant TB.
Conditions Studied
Study Locations (13)
New York
- Addiction Research and Treatment Corp - Brooklyn
- Clinical Directors Network of Region II - New York
- Harlem AIDS Treatment Group / Harlem Hosp Ctr - New York
- Bronx Lebanon Hosp Ctr - The Bronx
Michigan
- Comprehensive AIDS Alliance of Detroit - Detroit
- Henry Ford Hosp - Detroit
Colorado
- Denver CPCRA / Denver Public Hlth - Denver
District of Columbia
- Veterans Administration Med Ctr / Regional AIDS Program - Washington D.C.
Illinois
- AIDS Research Alliance - Chicago - Chicago
Louisiana
- Louisiana Comm AIDS Rsch Prog / Tulane Univ Med - New Orleans
New Jersey
- North Jersey Community Research Initiative - Newark
Oregon
- Portland Veterans Adm Med Ctr / Rsch & Education Grp - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,509 participants |
| Start Date | 1992-08 |
| Est. Completion | 1994-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00000785
The ClinicalTrials.gov registry entry for NCT00000785 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,509 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 443-participant average among 542 other HIV Infections trials with a reported enrollment target (241% higher). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 0 interventions.
NCT00000785 reports 13 study locations spanning 9 distinct geographic areas - top geographies include New York, Michigan, Colorado.
Frequently Asked Questions
What is clinical trial NCT00000785 about?
NCT00000785 is a clinical study titled "A Registry of Tuberculosis Cases in the CPCRA". PRIMARY: To estimate the proportion of tuberculosis patients in the CPCRA who have drug-resistant tuberculosis (TB) and to describe the patterns of drug resistance. SECONDARY: To compare drug resistance data on the Mycobacterium tuberculosis isolates of HIV-infected patients to those of HIV-uninfec...
What is the current status of trial NCT00000785?
This trial is currently completed. The enrollment target is 1,509 participants. The study started on 1992-08. Estimated completion is 1994-06.
What conditions does trial NCT00000785 study?
This clinical trial studies the following conditions: HIV Infections, Tuberculosis.
Who is sponsoring clinical trial NCT00000785?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000785 being conducted?
This trial has 13 study locations across Colorado, District of Columbia, Illinois, Louisiana, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
CAR-T Cells for HIV Infection
RECRUITING · Phase 1
-
A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV
RECRUITING · Phase 1
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.